These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 20100960)

  • 21. The risk of breast cancer associated with specific patterns of migraine history.
    Lowry SJ; Malone KE; Cushing-Haugen KL; Li CI
    Cancer Causes Control; 2014 Dec; 25(12):1707-15. PubMed ID: 25359301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benign Breast Disease, NSAIDs, and Postmenopausal Breast Cancer Risk in the CPS-II Cohort.
    Sherman ME; Vierkant RA; Masters M; Radisky DC; Winham SJ; Degnim AC; Vachon CM; Patel AV; Teras LR
    Cancer Prev Res (Phila); 2023 Mar; 16(3):175-184. PubMed ID: 36596665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Food sources of fat and sex hormone receptor status of invasive breast tumors in women of the Malmö Diet and Cancer cohort.
    Wirfält E; Li C; Manjer J; Ericson U; Sonestedt E; Borgquist S; Landberg G; Olsson H; Gullberg B
    Nutr Cancer; 2011; 63(5):722-33. PubMed ID: 21767080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proportion of premenopausal and postmenopausal breast cancers attributable to known risk factors: Estimates from the E3N-EPIC cohort.
    Dartois L; Fagherazzi G; Baglietto L; Boutron-Ruault MC; Delaloge S; Mesrine S; Clavel-Chapelon F
    Int J Cancer; 2016 May; 138(10):2415-27. PubMed ID: 26756677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative.
    Harris RE; Chlebowski RT; Jackson RD; Frid DJ; Ascenseo JL; Anderson G; Loar A; Rodabough RJ; White E; McTiernan A;
    Cancer Res; 2003 Sep; 63(18):6096-101. PubMed ID: 14522941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of nonsteroidal anti-inflammatory drugs and breast cancer risk in a prospective cohort of postmenopausal women.
    Cairat M; Al Rahmoun M; Gunter MJ; Severi G; Dossus L; Fournier A
    Breast Cancer Res; 2020 Oct; 22(1):118. PubMed ID: 33129324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alcohol consumption and breast cancer risk among women from five ethnic groups with light to moderate intakes: the Multiethnic Cohort Study.
    Park SY; Kolonel LN; Lim U; White KK; Henderson BE; Wilkens LR
    Int J Cancer; 2014 Mar; 134(6):1504-10. PubMed ID: 24037751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Population attributable risk of invasive postmenopausal breast cancer and breast cancer subtypes for modifiable and non-modifiable risk factors.
    Barnes BB; Steindorf K; Hein R; Flesch-Janys D; Chang-Claude J
    Cancer Epidemiol; 2011 Aug; 35(4):345-52. PubMed ID: 21159569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dietary acrylamide intake and estrogen and progesterone receptor-defined postmenopausal breast cancer risk.
    Pedersen GS; Hogervorst JG; Schouten LJ; Konings EJ; Goldbohm RA; van den Brandt PA
    Breast Cancer Res Treat; 2010 Jul; 122(1):199-210. PubMed ID: 19949857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lifetime use of nonsteroidal anti-inflammatory drugs and breast cancer risk: results from a prospective study of women with a sister with breast cancer.
    Kim S; Shore DL; Wilson LE; Sanniez EI; Kim JH; Taylor JA; Sandler DP
    BMC Cancer; 2015 Dec; 15():960. PubMed ID: 26673874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies.
    Enger SM; Ross RK; Paganini-Hill A; Carpenter CL; Bernstein L
    Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):681-7. PubMed ID: 10919738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adult weight gain in relation to breast cancer risk by estrogen and progesterone receptor status: a meta-analysis.
    Vrieling A; Buck K; Kaaks R; Chang-Claude J
    Breast Cancer Res Treat; 2010 Oct; 123(3):641-9. PubMed ID: 20711809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum enterolactone and postmenopausal breast cancer risk by estrogen, progesterone and herceptin 2 receptor status.
    Zaineddin AK; Vrieling A; Buck K; Becker S; Linseisen J; Flesch-Janys D; Kaaks R; Chang-Claude J
    Int J Cancer; 2012 Mar; 130(6):1401-10. PubMed ID: 21544804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phytoestrogen intake from foods, during adolescence and adulthood, and risk of breast cancer by estrogen and progesterone receptor tumor subgroup among Ontario women.
    Anderson LN; Cotterchio M; Boucher BA; Kreiger N
    Int J Cancer; 2013 Apr; 132(7):1683-92. PubMed ID: 22907507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estrogen receptor, Progesterone receptor, HER2 status and Ki67 index and responsiveness to adjuvant tamoxifen in postmenopausal high-risk breast cancer patients enrolled in the DBCG 77C trial.
    Knoop AS; Lænkholm AV; Jensen MB; Nielsen KV; Andersen J; Nielsen D; Ejlertsen B;
    Eur J Cancer; 2014 May; 50(8):1412-21. PubMed ID: 24675287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic effect between alcohol and estrogen replacement therapy on risk of breast cancer differs by estrogen/progesterone receptor status in the Iowa Women's Health Study.
    Gapstur SM; Potter JD; Drinkard C; Folsom AR
    Cancer Epidemiol Biomarkers Prev; 1995 Jun; 4(4):313-8. PubMed ID: 7655324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between family history of cancer and breast cancer defined by estrogen and progesterone receptor status.
    Tutera AM; Sellers TA; Potter JD; Drinkard CR; Wiesner GL; Folsom AR
    Genet Epidemiol; 1996; 13(2):207-21. PubMed ID: 8722747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estrogen-alone therapy and invasive breast cancer incidence by dose, formulation, and route of delivery: findings from the WHI observational study.
    Shufelt C; Bairey Merz CN; Pettinger MB; Choi L; Chlebowski R; Crandall CJ; Liu S; Lane D; Prentice R; Manson JE;
    Menopause; 2018 Sep; 25(9):985-991. PubMed ID: 29738414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
    Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
    J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breast cancer-specific survival by clinical subtype after 7 years follow-up of young and elderly women in a nationwide cohort.
    Johansson ALV; Trewin CB; Hjerkind KV; Ellingjord-Dale M; Johannesen TB; Ursin G
    Int J Cancer; 2019 Mar; 144(6):1251-1261. PubMed ID: 30367449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.